Method for the treatment of discogenic sciatica

 

(57) Abstract:

The invention relates to medicine, in particular to physiotherapy. Conduct impact high-intensity pulsed laser radiation with 1 to 5 fields with a diameter of 4 to 8 cm remotely a wavelength of 580 to 600 nm, with a pulse repetition frequency 1 Hz to 3 Hz, power density of the radiation pulse 10 W/cm2- 200 kW/cm2the dose of 0.2 - 25 j/cm2in 40 seconds - 20 minutes Way individualiziruyut by adjustment of the above parameters in the specified ranges during the course of treatment 4 to 7 sessions and repetition after 2 to 3 weeks. This increases the effectiveness of treatment, reduced treatment time, and in the process of conducting laser treatment of discogenic radiculitis eliminated complications. table 1.

The invention relates to medicine, in particular physiotherapy.

Known methods of treatment of intervertebral disc herniation by operational impact to the production of laminectomy and removal of herniated disc, intradiscal injection sklerosiruuschem drugs, underwater traction and manual therapy. [1,2].

Surgical intervention leads to long-term posleoperatsionnom period of rehabilitati the e operation was started only 46% of patients.

The closest is a method of treatment of radiculitis using low-energy helium-neon, helium-cadmium, and semiconductor lasers [3]. However, this method due to the low penetrating power of radiation data of lasers in tissue lengthy and inefficient. For this category of patients treated in hospitals, clinics or specialized hospital - sanatorium often takes several months, even with the use of alternation of various methods of physiotherapy. This leads to long terms of trumpeter and transfer of patients on disability.

The technical essence of the invention consists in increasing the efficiency and reducing treatment time.

This objective is achieved in that in the method of treatment of discogenic radiculitis by physical impact factor, according to the invention influence conduct high-intensity recomposit laser radiation with 1-5 sighting fields 4-8 cm in diameter remotely (transcutaneous) in the visible spectral range, when the pulse repetition frequency of 1-3 Hz, power density of the radiation pulse 10 W/cm2- 200 kW/cm2the dose of 0.2 - 25 j/cm2within 40 20 min and the individual is 4 to 7 sessions and repeat courses through 2 - 3 weeks.

The method is as follows. After a comprehensive evaluation, setting range, indication for conservative treatment and appointment of laser therapy is controlled cutaneous planning the radiation field. The treatment begins with exposure to the primary focus with the focus of the field of irradiation on the herniated disc. If necessary, use the advanced or additional fields of irradiation with the inclusion of paravertebral or remote radicular impact zones. The flexible light guide with locking device allows you to release patient procedure in a convenient position, optimizing conditions and irradiation technology. This provides a natural relaxation of the soft tissues in the affected area. The planned irradiation field is carried out in a pulsed mode with a pulse repetition frequency 1 Hz to 3 Hz, in the visible spectral range under power density of the radiation pulse from 10 W/cm2up to 200 kW/cm2and the dose of 0.2 - 25 j/cm2in the period from 40 to 20 minutes

The minimum parameters used in the acute form of the lesion, and the maximum chronic. The treatment is carried out daily. General treatment SOS is BA studied 135 patients with discogenic sciatica in age from 26 to 64 years (44.35.6 years), of which 92% were men. In 85% of cases of radicular syndrome is the result of abdominal compression of the intervertebral disc lumbar roots - krestsovoy region (L4-5C1). In 63% of patients starting point in the development of lesions was the injury expressed in the face of degenerative changes of the spine. In 46% of patients had a severe form of the disease, where the leading complaint was sick syndrome, limitation of motion, curvature of the spine, impaired sensitivity, parasthesia. In all patients the diagnosis was established after a thorough clinical and instrumental and laboratory investigations. More frequently posterolateral herniated discs of the lumbar-krestsovoy area. Taking into account indications of mi patients was planned surgical treatment, which for one reason or another (often the refusal of the patient) was not conducted. After the abolition of all kinds of traditional physiotherapy (except massage and exercise therapy) patients went to therapy high-intensity pulsed laser radiation (WHILE). Proof of the possibility of achieving positive results are indicators of the effectiveness of laser therapy WHILE (table), confirmed by clinical radiologists who ω military Clinical hospital. N. N. Burdenko since 1984 and Bashkir Republican Oncology center since 1992.

The clinical course observed by us patients treated moderate. The majority of patients (82%) were cured permanently, others on an outpatient basis. The average number of days of treatment when therapy WHILE was 9 days. In the control group (46 patients) in the treatment without laser therapy treatment averaged 36 days. A significant reduction in treatment time associated with pathological features of laser therapy VIILI. After 2-3 procedures using x-ray and CT studies indicated the beginning of the reduction of the herniated disc. In 78% of cases start reducing the pain occurred after 1 to 2 treatments.

As the table shows, 15% of patients managed on average after 6 treatments to achieve practical recovery, 59% - a significant improvement and the treatment was discontinued due to the resistance of patients to treatment method. In 17% of patients after a significant reduction in pain was observed short-term (1-2 days) wavy increase in pain, but the latter did not reach the initial intensity, therefore, could not be interpreted as a worsening in the quality of motion in the spine, restored function of the movement of the patient, decreased or disappeared curvature of the spine, pain, parasthesia. Improved the General condition of the patient (sleep, appetite, mood, and function of the intestine).

To illustrate the above material examples of clinical observations of patients with end-parameters of laser therapy VIILI.

Example 1.

Patient M. , 42 years old, was admitted for treatment on February 22, 1990 (history of the patient N 2806). Diagnosed with lateral herniated disc L4-L5with radicular syndrome L5on the right side. Complained of sharp pain in the lumbar region with irradiation on the outer surface of the right femur and tibia, limitation of motion in the lower back, the inability to move independently. Pain for 12 years. Onset connects with hypothermia after physical work, there are annual exacerbation. Were outpatients, thrice in the hospital. Last worsening appeared a month ago, was hospitalized. Position in bed - forced, on the left side, legs bent. Noted moderate right-sided scoliosis and muscle tension. Palpation of the spinous processes of Lasaga from the corner to the right - 12oleft 50o. On radiographs of the spine, lumbar lordosis, smooth bodies L4- L5. If pneumonology revealed a bulge is noticeable intervertebral disc L4- L5on the right side. Conducted conservative treatment (medication, scuba stretching, massage, physiotherapy) effect is not given. The patient started treatment WHILE. The treatment was carried out with a single direct lumbar-sacral field diameter of 4 cm with a focus on each projection of the lateral herniated disc on the right, with the inclusion of the right paravertebral area of this level of laser radiation with a wavelength of 580 to 600 nm, a pulse repetition frequency of 1 Hz and a power density of the pulse of radiation 10 W/cm2at the dose of 0.2 j/cm240 pulses per session. The course of treatment consisted of 4 sessions. Directly after the first session of laser therapy was noted a decrease in pain within 25-50% of the original, after the second - a noticeable improvement. Increased mobility of the spine (the patient can walk on the branch), improved sensitivity on the right foot. Treatments 3, 4 wore establishing the character. Discharged with significant improvement. Aimed at outpatient re. Examination of six months clinical effect is persistent.

Example 2.

Patient E., 53. Was admitted to the hospital on 7 January 1991 (patient records N 127) with complaints of pain in the lumbar region with irradiation in the right buttock, thigh and drumstick, with severe numbness in the outer surface of the right leg and foot. Ill for 10 years. The disease is connected with injury. Were outpatients and folk remedies without much effect. Recent aggravation lasts 8 months, including 3 months was on sick leave. Objectively: the patient is unable to straighten up and walk, position in bed - bent on the left side. Right-sided scoliosis and kyphosis of the lumbar spine. Divans lumbar muscles on the right. Knee and plantar reflexes to the right somewhat reduced, ankle - none. When we tap on the spinous processes of the L5and C1exacerbated pain along the C1of the spine. Symptom Lasaga right 35othe left 50o. On computerized tomography of the spine with right - sided scoliosis, a sharp narrowing of the gap L5- C1with intervertebral disc herniation on the right. Final diagnosis: herniated disc L5-C1with radicular syndrome is imal comprehensive treatment: analgesics and dissimilitude means, ultrasound, amplipulse, UV treatment, irradiation with helium-neon laser (10 sessions), mud, underwater traction, massage, exercise therapy. A noticeable improvement was observed. After a week's break started a course of laser therapy VIILI.

The treatment was carried out with 5 direct fields: lumbar-sacral, right gluteal, thigh, lower leg and ankle with a diameter of 8 cm remotely on the projection Express parcel pain syndrome on the posterolateral surface of the right lower limb. Applied pulsed laser irradiation with a wavelength of 580 to 600 nm, pulse frequency of 3 Hz, the density of radiation power 200 kW/cm2at the dose of 25 j/cm2within 20 minutes after the Course of treatment consisted of 7 treatments. A noticeable reduction in pain was noted after conducting 2 procedures (40%), after 4 treatments show significant improvement. Virtually pain is not worried. Celebrated landmark sequence reduce pain, since the lumbar-sacral division, buttocks, thighs and shins. The patient stood up, began to walk around the office and procedures. After a 10-day rehabilitation course therapy with practical recovery was discharged home. After a year had no complaints. Notes Engaged in self-rehabilitation of physical education.

References

1. Shustin B. A. Panyushkin A. I. Clinic and surgical treatment of discogenic lumbar-grescovich of ridiculosity. HP: Medicine 1985

2. Ermolenko C. F. Sucina Century. And. the Outcomes of treatment of discogenic lumbar-grescovich of radiculitis. Current issues of diagnosis and treatment in a multidisciplinary hospital, 1 o'clock. M: Votesd., 1990, S. 274.

3. Shooters N. And. Diseases of the nervous system (radiculitis). Guide to physical therapy edited by Prof. one Century, M.: Medicine, 1992, S. 181-186.

Method for the treatment of discogenic radiculitis by physical impact factor, characterized in that the impact of conducting high-intensity pulsed laser radiation with 1 to 5 fields with a diameter of 4 to 8 cm remotely a wavelength of 580 to 600 nm, with a pulse repetition frequency 1 Hz to 3 Hz, power density of the radiation pulse 10 W/cm2- 200 kW/cm2the dose of 0.2 - 25 j/cm2within 40 20 min and individualization of the way through the adjustment of the above parameters in the specified ranges during the course of treatment 4 to 7 sessions and repetition in 2-3 weeks.

 

Same patents:

The invention relates to medicine, namely to methods for treating electromagnetic radiation

The invention relates to medicine, namely to methods of treatment of trophic ulcers of low-intensity laser radiation
The invention relates to medicine, namely to dermatology
The invention relates to urology and is intended to be a comprehensive treatment of chronic urethritis, urogenital infections caused
The invention relates to medicine, namely to the rehabilitation of hemodynamic disturbances associated with physical activity in overload mode
The invention relates to urology and is intended for the integrated treatment endourethral warts
The invention relates to urology and is intended for the integrated treatment of strictures of the urethra, caused by urogenital infections

The invention relates to medical equipment
The invention relates to medicine, namely to thoracic surgery

FIELD: medicine.

SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.

EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.

3 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.

EFFECT: complete destruction of neoplasm; excluded its further growth.

4 cl

FIELD: medicine.

SUBSTANCE: method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2. the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2.

EFFECT: complete destruction of neoplasm; excluded tumor recurrence; reduced risk of tumor cells dissemination.

3 cl, 3 dwg

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

EFFECT: higher therapeutic and cosmetic effect.

1 ex

FIELD: medicine.

SUBSTANCE: method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2.The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2. The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

EFFECT: reduced risk of metastasizing.

4 cl, 13 dwg

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2 in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

EFFECT: complete destruction of neoplasm; reduced dissemination risk.

6 cl, 12 dwg

FIELD: medicine, applicable for stopping of pains of various nature.

SUBSTANCE: the device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

EFFECT: quick and absolute anestesia.

2 ex, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves administering laser radiation therapy once a day using low intensity pulsating radiation of wavelength equal to 890nmand power density of 0.03 mW/cm2. Injured organ projection to frontal abdominal wall is exposed to radiation at the first laser therapy stage in two fields acting upon each field for 2 min with radiation pulse succession frequency equal to 80 Hz in applying stable contact-type method. Total treatment dose on two fields is equal to 0.008 J/cm2. The second laser therapy stage begins immediately after having finished the first one in applying radiation along the large intestine path using labile contact-type method in a way that radiation pulse succession frequency equal to 80 Hz is applied first during 1 min and then frequencies of 600, 150 and 300 Hz are applied also during 1 min, respectively. Total treatment dose is equal to 0.032 J/cm2 at the second stage. Total treatment dose is equal to 0.04 J/cm2 at both stages.

EFFECT: enhanced effectiveness in inhibiting dysbacteriosis; reduced frequency of postoperative complications.

Up!